Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Integrated omics approaches provide strategies for rapid erythromycin yield increase in Saccharopolyspora erythraea
Avtorji:ID Karničar, Katarina (Avtor)
ID Drobnak, Igor (Avtor)
ID Petek, Marko (Avtor)
ID Magdevska, Vasilka (Avtor)
ID Horvat, Jaka (Avtor)
ID Vidmar, Robert (Avtor)
ID Baebler, Špela (Avtor)
ID Rotter, Ana (Avtor)
ID Jamnik, Polona (Avtor)
ID Fujs, Štefan (Avtor)
ID Turk, Boris (Avtor)
ID Fonović, Marko (Avtor)
ID Gruden, Kristina (Avtor)
ID Kosec, Gregor (Avtor)
ID Petković, Hrvoje (Avtor)
Datoteke:URL URL - Izvorni URL, za dostop obiščite http://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-016-0496-5
 
.pdf PDF - Predstavitvena datoteka, prenos (3,06 MB)
MD5: 4D09F98BE6286B0D28E9ECC5618EB48E
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo NIB - Nacionalni inštitut za biologijo
Logo IJS - Institut Jožef Stefan
Povzetek:Background Omics approaches have significantly increased our understanding of biological systems. However, they have had limited success in explaining the dramatically increased productivity of commercially important natural products by industrial high-producing strains, such as the erythromycin-producing actinomycete Saccharopolyspora erythraea. Further yield increase is of great importance but requires a better understanding of the underlying physiological processes. Results To reveal the mechanisms related to erythromycin yield increase, we have undertaken an integrated study of the genomic, transcriptomic, and proteomic differences between the wild type strain NRRL2338 (WT) and the industrial high-producing strain ABE1441 (HP) of S. erythraea at multiple time points of a simulated industrial bioprocess. 165 observed mutations lead to differences in gene expression profiles and protein abundance between the two strains, which were most prominent in the initial stages of erythromycin production. Enzymes involved in erythromycin biosynthesis, metabolism of branched chain amino acids and proteolysis were most strongly upregulated in the HP strain. Interestingly, genes related to TCA cycle and DNA-repair were downregulated. Additionally, comprehensive data analysis uncovered significant correlations in expression profiles of the erythromycin-biosynthetic genes, other biosynthetic gene clusters and previously unidentified putative regulatory genes. Based on this information, we demonstrated that overexpression of several genes involved in amino acid metabolism can contribute to increased yield of erythromycin, confirming the validity of our systems biology approach. Conclusions Our comprehensive omics approach, carried out in industrially relevant conditions, enabled the identification of key pathways affecting erythromycin yield and suggests strategies for rapid increase in the production of secondary metabolites in industrial environment.
Ključne besede:aktinomicete, Saccharopolyspora erythraea, sekundarni metaboliti, antibiotiki, eritromicin, biosinteza, metabolno inženirstvo, proteomika
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Datum objave:03.06.2016
Leto izida:2016
Št. strani:str. 1/17-17/17
Številčenje:Vol. 15, no. 93
PID:20.500.12556/DiRROS-19792 Novo okno
UDK:604.4:615.332:579.873:577.2
ISSN pri članku:1475-2859
DOI:10.1186/s12934-016-0496-5 Novo okno
COBISS.SI-ID:4655992 Novo okno
Opomba:Soavtorji: Igor Drobnak, Marko Petek, Vasilka Magdevska, Jaka Horvat, Robert Vidmar, Špela Baebler, Ana Rotter, Polona Jamnik, Štefan Fujs, Boris Turk, Marko Fonovič, Kristina Gruden, Gregor Kosec, Hrvoje Petković; Nasl. z nasl. zaslona; Opis vira z dne 6. 6. 2016;
Datum objave v DiRROS:25.07.2024
Število ogledov:367
Število prenosov:218
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Microbial cell factories
Skrajšan naslov:Microb Cell Fact
Založnik:BioMed Central
ISSN:1475-2859
COBISS.SI-ID:2609172 Novo okno

Gradivo je financirano iz projekta

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:J4-2195-2009
Naslov:Preučevanje biosinteze eritromicina s proteomskimi orodji

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P1-0140-2015
Naslov:Proteoliza in njena regulacija

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:J1-4121-2011
Naslov:Vloga cisteinskih katepsinov pri celičnem signaliziranju

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:J4-4149-2011
Naslov:Preučevanje hom(e)olognih rekombinacij v evoluciji poliketidnih sintaz

Financer:Drugi - Drug financer ali več financerjev
Program financ.:European Regional Development Fund and the Government of Slovenia, Ministry of Education, Science and Sport
Naslov:“KC Brin competence centre” grant

Financer:Drugi - Drug financer ali več financerjev
Program financ.:European Social Fund and the Ministry of Economic Development and Technology
Številka projekta:C2130-14-090124
Naslov:“KROP” Grant

Financer:Drugi - Drug financer ali več financerjev
Program financ.:Slovenian Technology Agency—TIA/SPIRIT
Številka projekta:P-MR-09/103
Naslov:young researcher grant

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Nazaj